Cost analysis of Mohs micrographic surgery in high-risk facial basal cell carcinoma;Anlisis de costes de la ciruga microgrfica de Mohs en el carcinoma basocelular facial de alto riesgo

Actas Dermo-Sifiliograficas

Volumn 101, Issue 7, 2010, Pages 622-628

  Blzquez Snchez, N ^a   De Troya Martn, M ^a   Frieyro Elicegui, M ^a   Fnez Libana, R ^a   Martn Mrquez, L ^a   Rivas Ruiz, F ^a  

^a HOSPITAL COSTA DEL SOL   (Spain)

Author keywords

Cost analysis; Cost effectiveness; Micrographic surgery; Mohs

Indexed keywords

ADULT; ARTICLE; BASAL CELL CARCINOMA; CANCER RISK; CANCER SIZE; CANCER SURGERY; CONTROLLED STUDY; COST BENEFIT ANALYSIS; CROSS-SECTIONAL STUDY; DESCRIPTIVE RESEARCH; DISEASE SEVERITY; FACE CANCER; FACIAL BASAL CELL CARCINOMA; FEMALE; HISTOPATHOLOGY; HOSPITAL COST; HUMAN; MAJOR CLINICAL STUDY; MALE; MOHS MICROGRAPHIC SURGERY; NOSE; RECURRENT DISEASE; SKIN FLAP; SKIN GRAFT; SPAIN; STATISTICAL SIGNIFICANCE; CHEMOSURGERY; COST; ECONOMICS; FACE TUMOR; MIDDLE AGED; RISK FACTOR; SKIN TUMOR;

CARCINOMA, BASAL CELL; COSTS AND COST ANALYSIS; CROSS-SECTIONAL STUDIES; FACIAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; MOHS SURGERY; RISK FACTORS; SKIN NEOPLASMS;

EID: 77956853795     PISSN: 00017310     EISSN: 15782190     Source Type: Journal    
DOI: 10.1016/j.ad.2010.02.010     Document Type: Article

References (22)

1. K. Mosterd, G.A. Krekels, F.H. Nieman, J.U. Ostertag, B.A. Essers, and C.D. Dirksen Surgical escisin versus Mohs′micrographic surgery for primary and recurrent basal cell-carcinoma of the face: a prospective randomised controlled trial with 5-years′follow-up Lancet Oncol 9 2008 1149 1156
2. Bath-Hextall FJ, Perkins W, Bong J, Williams HC. Interventions for basal cell carcinoma of the skin. Cochrane Database Syst Rev. 2007;1:CD003412
3. Leibovitch I, Huilgol SC, Selva D, Richards S, Paver R. Basal cell carcinoma treated with Mohs surgery in Australia II. Outcome at 5-year follow-up. Journal of the American Academy of Dermatology. 2005; 53: 4527. (Pubitemid 41195967)
4. D.E. Rowe, R.J. Carroll, and C.L. Day Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up J Dermatol Surg Oncol 15 1989 315 328
5. N.R. Telfer, G.B. Colver, and C.A. Morton Guidelines for the management of basal cell carcinoma Br J Dermatol 159 2008 35 48
6. J. Cook, and J.A. Zitelli Mohs micrographic surgery: a cost analisis J Am Acad Dermatol 39 5 Pt 1 1998 698 703
7. T.L. Bialy, J. Whalen, E. Veledar, D. Lafreniere, J. Spiro, and T. Chartier Mohs micrographic surgery vs tradicional surgical escisin. A cost comparison anlisis Arch Dermatol 140 2004 736 742
8. B.A.B. Essers, C.D. Dirksen, F.H.M. Nieman, N.W. Smeets, G.A. Krekels, and M.H. Prins Cost-effectiveness of Mohs micrographic surgery vs surgical excision of basal cell carcinoma of the face Arch Dermatol 142 2006 187 194
9. S.Y. Then, R. Malhotra, R. Barlow, H. Kurwa, S. Huilgol, and N. Joshi Early cure rates with narrow-margin slow-Mohs surgery for periocular malignant melanoma Dermatol Surg 35 2009 17 23
10. B. Stenquist, M.B. Ericson, C. Strandeberg, L. Mlne, A. Rosn, and O Lark Bispectral fluorescence imaging of aggressive basal cell carcinoma combined with histopathological mapping: a preliminary study indicating a possible adjunct to Mohs micrographic surgery Br J Dermatol 154 2006 305 309
11. P. Redondo, M. Marquina, M. Pretel, L. Aguado, and M.E. Iglesias Methyl-ALA induced fluorescence in photodynamic diagnoses of basal cell carcinoma prior to Mohs micrographic surgery Arch Dermatol 144 2008 115 117
12. A. Jambusaria-Pahlajani, C. Schmults, C. Miller, D. Shin, J. Williams, and S.K. Kurd Test characteristics of high-resolution ultrasound in the preoperative assessment of margins of basal cell squamous cell carcinoma in patients undergoing Mohs micrographic surgery Dermatol Surg 35 2009 9 16
13. J.K. Karen, D.S. Gareu, S.W. Duzsa, M. Tudisco, M. Rajadhyaksha, and K.S. Nehal Detection of basal cell carcinomas in Mohs excisions with fluorescente confocal mosaicing microscopy Br J Dermatol 160 2009 240 245
14. R. Alkalay, J. Alkalay, A. Maly, A. Ingber, C. Fritsch, and T. Ruzicka Fluorescence imaging for demarcation of basal cell carcinoma tumor borders J Drugs Dermatol 7 2008 1033 1037
15. V.Q. Chung, P.J. Dwyer, K.S. Nehal, M. Rajadhyaksha, G.M. Menaker, and C. Charles Use of ex vivo confocal laser microscopy during Mohs surgery for non melanoma skin cancer Dermatol Surg 30 2004 1470 1478
16. R.N. Downes, N.P. Walker, and J.R. Collin Micrographic (Mohs′) surgery in the management of periocular basal cell epitheliomas Eye (Lond) 4 1990 160 168
17. I. Leibovitch, S.C. Huilgol, D. Selva, S. Richards, and R. Paver Basal cell carcinoma treated with Mohs surgery in Australia. Outcome at 5-year follow-up J Am Acad Dematol 151 2004 141 147
18. C. Leiter, and U. Gaiber Epidemiology of melanoma andnonmelanoma skin cancer-the role of sunlight Adv Exp Med Biol 624 2008 89 103
19. R.S. Batra, and L.C. Kelley Predictors of extensive subclinical spread in nonmelanoma skin cancer treated with MOhs micrographic surgery Arch Dermatol 138 2002 1043 1051
20. I.F. Orengo, S.J. Salasche, J. Fewkes, J. Khan, J. Thornby, and F. Rubin Correlation of histologic subtypes of primary basal cell carcinoma and number of Mohs stages required to achieve a tumor-free plane J Am Acad Dermatol 37 Pt 1 1997 385 387
21. T. Alonso, P. Snchez, Gonzlez, J. Ingelmo, I. Ruiz, and S. Delgado Ciruga de Mohs: nuestros primeros 100 pacientes Actas Dermosifiliogr 99 2008 275 280
22. J.S. Rhee, B.A. Matthews, M. Neuburg, B.R. Logan, M. Burzynski, and A.B. Nattinger The skin cancer index: clinical responsiveness and predictors of quality of life Laryngoscope 117 2007 399 405